Stocks Showing Market Leadership: Novocure Earns 96 RS Rating
The IBD Screen Of The Day helps find top growth stocks based on the unique RS Rating, which measures a stock's technical performance. Stocks with RS Rating above 80 in early stages tend to be market winners. Novocure's recent performance and potential buying opportunities are discussed.